ketamine has been researched along with Disorder, Borderline Personality in 5 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study is the first randomized controlled trial to test the effects of ketamine in Borderline Personality Disorder (BPD)." | 9.69 | A pilot randomized controlled trial of ketamine in Borderline Personality Disorder. ( Choi, EY; Corlett, PR; Dhaliwal, K; Fineberg, SK; Krystal, JH; Neustadter, E; Null, K; Peters, JR; Pittaro, GF; Rondeau, J; Sakheim, M; Shapiro-Thompson, R; Trujillo-Diaz, D, 2023) |
| "This case presents a female patient diagnosed with both Bipolar Disorder (BD) and Borderline Personality Disorder (BPD) who received intravenous ketamine treatment to alleviate acute depressive symptoms." | 8.31 | Short term ketamine treatment in patient with bipolar disorder with comorbidity with borderline personality disorder: Focus on impulsivity. ( Cubała, WJ; Gałuszko-Węgielnik, M; Jakuszkowiak-Wojten, K; Wilkowska, A, 2023) |
| "Ketamine is a potentially life-saving option." | 5.72 | The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder. ( Chen, KS; Dwivedi, Y; Shelton, RC, 2022) |
| "This study is the first randomized controlled trial to test the effects of ketamine in Borderline Personality Disorder (BPD)." | 5.69 | A pilot randomized controlled trial of ketamine in Borderline Personality Disorder. ( Choi, EY; Corlett, PR; Dhaliwal, K; Fineberg, SK; Krystal, JH; Neustadter, E; Null, K; Peters, JR; Pittaro, GF; Rondeau, J; Sakheim, M; Shapiro-Thompson, R; Trujillo-Diaz, D, 2023) |
| "This case presents a female patient diagnosed with both Bipolar Disorder (BD) and Borderline Personality Disorder (BPD) who received intravenous ketamine treatment to alleviate acute depressive symptoms." | 4.31 | Short term ketamine treatment in patient with bipolar disorder with comorbidity with borderline personality disorder: Focus on impulsivity. ( Cubała, WJ; Gałuszko-Węgielnik, M; Jakuszkowiak-Wojten, K; Wilkowska, A, 2023) |
| "Ketamine is a potentially life-saving option." | 1.72 | The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder. ( Chen, KS; Dwivedi, Y; Shelton, RC, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vanicek, T | 1 |
| Unterholzner, J | 1 |
| Lanzenberger, R | 1 |
| Naderi-Heiden, A | 1 |
| Kasper, S | 1 |
| Praschak-Rieder, N | 1 |
| Chen, KS | 1 |
| Dwivedi, Y | 1 |
| Shelton, RC | 1 |
| Fineberg, SK | 1 |
| Choi, EY | 1 |
| Shapiro-Thompson, R | 1 |
| Dhaliwal, K | 1 |
| Neustadter, E | 1 |
| Sakheim, M | 1 |
| Null, K | 1 |
| Trujillo-Diaz, D | 1 |
| Rondeau, J | 1 |
| Pittaro, GF | 1 |
| Peters, JR | 1 |
| Corlett, PR | 1 |
| Krystal, JH | 1 |
| Danayan, K | 1 |
| Chisamore, N | 1 |
| Rodrigues, NB | 1 |
| Vincenzo, JDD | 1 |
| Meshkat, S | 1 |
| Doyle, Z | 1 |
| Mansur, R | 1 |
| Phan, L | 1 |
| Fancy, F | 1 |
| Chau, E | 1 |
| Tabassum, A | 1 |
| Kratiuk, K | 1 |
| Arekapudi, A | 1 |
| Teopiz, KM | 1 |
| McIntyre, RS | 1 |
| Rosenblat, JD | 1 |
| Gałuszko-Węgielnik, M | 1 |
| Jakuszkowiak-Wojten, K | 1 |
| Wilkowska, A | 1 |
| Cubała, WJ | 1 |
2 trials available for ketamine and Disorder, Borderline Personality
| Article | Year |
|---|---|
A pilot randomized controlled trial of ketamine in Borderline Personality Disorder.
Topics: Adult; Antidepressive Agents; Borderline Personality Disorder; Double-Blind Method; Humans; Ketamine | 2023 |
Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder.
Topics: Borderline Personality Disorder; Canada; Depression; Depressive Disorder, Treatment-Resistant; Human | 2023 |
3 other studies available for ketamine and Disorder, Borderline Personality
| Article | Year |
|---|---|
Intravenous esketamine leads to an increase in impulsive and suicidal behaviour in a patient with recurrent major depression and borderline personality disorder.
Topics: Antidepressive Agents; Borderline Personality Disorder; Depression; Depressive Disorder, Major; Depr | 2022 |
The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder.
Topics: Adult; Antidepressive Agents; Borderline Personality Disorder; Depressive Disorder, Major; Humans; K | 2022 |
Short term ketamine treatment in patient with bipolar disorder with comorbidity with borderline personality disorder: Focus on impulsivity.
Topics: Antidepressive Agents; Bipolar Disorder; Borderline Personality Disorder; Comorbidity; Female; Human | 2023 |